Nurix Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Nurix Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Nurix Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Nurix Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $2.5M | 169k | 14.70 |
| 2023-12-31 | $795k | 76k | 10.40 |
| 2023-09-30 | $1.4M | 172k | 7.86 |
| 2023-06-30 | $806k | 81k | 9.99 |
| 2023-03-31 | $756k | 85k | 8.88 |
| 2022-12-31 | $1.6M | 144k | 11.00 |
| 2022-09-30 | $550k | 42k | 13.15 |
| 2022-06-30 | $752k | 59k | 12.67 |
| 2022-03-31 | $0 | 149k | 0.00 |
| 2021-12-31 | $2.9M | 99k | 28.95 |
| 2021-09-30 | $17k | 575 | 29.57 |
| 2021-06-30 | $518k | 20k | 26.52 |
| 2021-03-31 | $1.0M | 32k | 31.08 |